Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Heart Valve Diseases HELP
Based on 37,444 articles published since 2008
||||

These are the 37444 published articles about Heart Valve Diseases that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) / transcatheter aortic valve replacement (TAVR): An expert consensus document of the Society of Cardiovascular Computed Tomography. 2019

Blanke, Philipp / Weir-McCall, Jonathan R / Achenbach, Stephan / Delgado, Victoria / Hausleiter, Jörg / Jilaihawi, Hasan / Marwan, Mohamed / Norgaard, Bjarne L / Piazza, Niccolo / Schoenhagen, Paul / Leipsic, Jonathon A. ·Department of Radiology, St Paul's Hospital & University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: phil.blanke@gmail.com. · Department of Radiology, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom. · Department of Cardiology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. · Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, the Netherlands. · Medizinische Klinik und Poliklinik I der Ludwig-Maximilians-Universität München, Munich, Germany. · New York University Medical Center, NYC, NY, USA. · Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Blvd. 99, Aarhus, Denmark. · McGill University Health Centre, Montreal, QC, Canada. · Imaging Institute and Heart&Vascular Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA. · Department of Radiology, St Paul's Hospital & University of British Columbia, Vancouver, British Columbia, Canada. ·J Cardiovasc Comput Tomogr · Pubmed #30630686.

ABSTRACT: -- No abstract --

2 Guideline [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. 2018

Baumgartner, Helmut / Falk, Volkmar / Bax, Jeroen J / Bonis, Michele De / Hamm, Christian / Holm, Per Johan / Iung, Bernard / Lancellotti, Patrizio / Lansac, Emmanuel / Munoz, Daniel Rodriguez / Rosenhek, Raphael / Sjögren, Johan / Mas, Pilar Tornos / Vahanian, Alec / Walther, Thomas / Wendler, Olaf / Windecker, Stephan / Zamorano, Jose Luis. ·Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Niemcy. journals.permissions@oup.com. ·Kardiol Pol · Pubmed #29399765.

ABSTRACT: -- No abstract --

3 Guideline None 2017

Tarasoutchi, Flavio / Montera, Marcelo Westerlund / Ramos, Auristela Isabel de Oliveira / Sampaio, Roney Orismar / Rosa, Vitor Emer Egypto / Accorsi, Tarso Augusto Duenhas / Lopes, Antonio Sergio de Santis Andrade / Fernandes, João Ricardo Cordeiro / Pires, Lucas José Tachotti / Spina, Guilherme Sobreira / Vieira, Marcelo Luiz Campos / Lavitola, Paulo de Lara / Bignoto, Tiago Costa / Togna, Dorival Julio Della / Mesquita, Evandro Tinoco / Esteves, William Antonio de Magalhães / Atik, Fernando Antibas / Colafranceschi, Alexandre Siciliano / Moisés, Valdir Ambrósio / Kiyose, Alberto Takeshi / Pomerantzeff, Pablo Maria Alberto / Lemos Neto, Pedro Alves / Brito Júnior, Fábio Sândoli de / Weksler, Clara / Brandão, Carlos Manuel de Almeida / Poffo, Robinson / Simões, Ricardo / Rassi, Salvador / Leães, Paulo Ernesto / Rocha, Ricardo Mourilhe / Pena, José Luiz Barros / Jatene, Fabio Biscegli / Barbosa, Márcia de Melo / Souza Neto, João David de / Saraiva, José Francisco Kerr. · ·Arq Bras Cardiol · Pubmed #29513780.

ABSTRACT: -- No abstract --

4 Guideline [Management of valvular heart disease : ESC/EACTS guidelines 2017]. 2017

Haude, M. ·Medizinische Klinik I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Preußenstr. 84, 41464, Neuss, Deutschland. mhaude@lukasneuss.de. ·Herz · Pubmed #29188357.

ABSTRACT: After 5 years the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery have released an update on the guidelines for the management of valvular heart diseases. In recent years published results of randomized trials in patients with aortic valve stenosis have resulted in updated recommendations for catheter-based prosthesis implantation (TAVI), which is now extended to patients presenting without a low risk for conventional surgical valve replacement. In mitral or tricuspid valvular disease, the recommendations for catheter-based therapies are less strong because of a lack of supportive scientific data. A special focus of these updated guidelines is on concomitant antithrombotic therapy in valvular heart disease and in the context of a combination with coronary artery disease and/or accompanying arrhythmia. Special emphasis was again put on the multidisciplinary heart team for the diagnostics and treatment of patients with valvular heart disease. In order to support the quality of treatment for patients with valvular heart disease, it is suggested that heart valve centers of excellence should be established, which have to fulfil complex personnel, structural and technological prerequisites.

5 Guideline 2017 ESC/EACTS Guidelines for the management of valvular heart disease. 2017

Falk, Volkmar / Baumgartner, Helmut / Bax, Jeroen J / De Bonis, Michele / Hamm, Christian / Holm, Per Johan / Iung, Bernard / Lancellotti, Patrizio / Lansac, Emmanuel / Muñoz, Daniel Rodriguez / Rosenhek, Raphael / Sjögren, Johan / Tornos Mas, Pilar / Vahanian, Alec / Walther, Thomas / Wendler, Olaf / Windecker, Stephan / Zamorano, Jose Luis / Anonymous481042. · ·Eur J Cardiothorac Surg · Pubmed #29156023.

ABSTRACT: -- No abstract --

6 Guideline ACR Appropriateness Criteria 2017

Anonymous7830925 / Leipsic, Jonathon A / Blanke, Philipp / Hanley, Michael / Batlle, Juan C / Bolen, Michael A / Brown, Richard K J / Desjardins, Benoit / Eberhardt, Robert T / Gornik, Heather L / Hurwitz, Lynne M / Maniar, Hersh / Patel, Himanshu J / Sheybani, Elizabeth F / Steigner, Michael L / Verma, Nupur / Abbara, Suhny / Rybicki, Frank J / Kirsch, Jacobo / Dill, Karin E. ·Principal Author, St. Paul's Hospital, Vancouver, British Columbia, Canada. Electronic address: jleipsic@providencehealth.bc.ca. · Research Author, St. Paul's Hospital, Vancouver, British Columbia, Canada. · Panel Vice Chair (Vascular), University of Virginia Health System, Charlottesville, Virginia. · Miami Cardiac and Vascular Institute and Baptist Health of South Florida, Miami, Florida. · Cleveland Clinic, Cleveland, Ohio. · University of Michigan Health System, Ann Arbor, Michigan. · University of Pennsylvania, Philadelphia, Pennsylvania. · Boston University School of Medicine, Boston, Massachusetts; American College of Cardiology. · Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio; American College of Cardiology. · Duke University Medical Center, Durham, North Carolina. · University of Washington School of Medicine, Seattle, Washington; American Association for Thoracic Surgery. · University of Michigan Frankel Cardiovascular Center, Ann Arbor, Michigan; Society of Thoracic Surgeons. · Mercy Hospital, Saint Louis, Missouri. · Brigham & Women's Hospital, Boston, Massachusetts. · University of Florida, Gainesville, Florida. · Specialty Chair (Cardiac), UT Southwestern Medical Center, Dallas, Texas. · Specialty Chair (Vascular), Ottawa Hospital Research Institute and the Department of Radiology, The University of Ottawa, Ottawa, Ontario, Canada. · Panel Chair (Cardiac), Cleveland Clinic, Weston, Florida. · Panel Chair (Vascular), UMass Memorial Medical Center, Worcester, Massachusetts. ·J Am Coll Radiol · Pubmed #29101983.

ABSTRACT: Aortic stenosis is a common valvular condition with increasing prevalence in aging populations. When severe and symptomatic, the downstream prognosis is poor without surgical or transcatheter aortic valve replacement. Transcatheter aortic valve replacement is now considered a viable alternative to surgical aortic valve replacement in patients considered high and intermediate risk for surgery. Pre-intervention imaging with echocardiography and CT are essential for procedure planning and device selection to help optimize clinical outcomes with MR angiography playing largely a complementary role. Modern 3-D cross-sectional imaging has consistently shown to help reduce procedural complications from vascular access injury to paravalvular regurgitation and coronary obstruction. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

7 Guideline Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). 2017

Lip, Gregory Y H / Collet, Jean Philippe / Caterina, Raffaele de / Fauchier, Laurent / Lane, Deirdre A / Larsen, Torben B / Marin, Francisco / Morais, Joao / Narasimhan, Calambur / Olshansky, Brian / Pierard, Luc / Potpara, Tatjana / Sarrafzadegan, Nizal / Sliwa, Karen / Varela, Gonzalo / Vilahur, Gemma / Weiss, Thomas / Boriani, Giuseppe / Rocca, Bianca / Anonymous6210925. ·Institute of Cardiovascular Sciences, University of Birmingham and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark. · Sorbonne Université Paris 6, ACTION Study Group, Institut De Cardiologie, Groupe Hôpital Pitié-Salpetrière (APHP), INSERM UMRS 1166, Paris, France. · Institute of Cardiology, 'G. D'Annunzio' University, Chieti, Italy. · Centre Hospitalier Universitaire Trousseau et Faculté de Medicinde, Université François Rabelais, Tours, France. · Institute of Cardiovascular Sciences, University of Birmingham, United Kingdom; and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. · Thrombosis Research Unit,Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark. · Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. · Department of Cardiology, Leiria Hospital Centre, Leiria, Portugal. · Department of Cardiac Electrophysiology, Care Hospital, Hyderabad, India. · Mercy Hospital, Mason City, Iowa, USA. · Department of Cardiology, University Hospital Sart-Tilman, Liege, Belgium. · School of Medicine, Belgrade University; Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia. · Isfahan Cardiovascular Research Center (WHO Collaborating Center), Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran and School of Population and Public Health, University of British Columbia, Vancouver, Canada. · Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town, South Africa; and Mary McKillop Institute, ACU, Melbourne, Australia. · Servicio de Electrofisiología, Centro Cardiovascular Casa de Galicia, Hidalgos, Uruguay. · Cardiovascular Science Institute - ICCC, IIB-Sant Pau, CiberCV, Hospital de Sant Pau, Barcelona, Spain. · Medical Department For Cardiology and Intensive Care, Wilhelminenhospital, and Medical Faculty Sigmund Freud University, Vienna, Austria. · Cardiology Department, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy. · Institute of Pharmacology, Catholic University School of Medicine, Rome, Italy. ·Europace · Pubmed #29096024.

ABSTRACT: Atrial fibrillation (AF) is a major worldwide public health problem, and AF in association with valvular heart disease (VHD) is also common. However, management strategies for this group of patients have been less informed by randomized trials, which have largely focused on 'non-valvular AF' patients. Thrombo-embolic risk also varies according to valve lesion and may also be associated with CHA2DS2VASc score risk factor components, rather than only the valve disease being causal. Given marked heterogeneity in the definition of valvular and non-valvular AF and variable management strategies, including non-vitamin K antagonist oral anticoagulants (NOACs) in patients with VHD other than prosthetic heart valves or haemodynamically significant mitral valve disease, there is a need to provide expert recommendations for professionals participating in the care of patients presenting with AF and associated VHD. To address this topic, a Task Force was convened by the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Thrombosis, with representation from the ESC Working Group on Valvular Heart Disease, Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) with the remit to comprehensively review the published evidence, and to publish a joint consensus document on the management of patients with AF and associated VHD, with up-to-date consensus recommendations for clinical practice for different forms of VHD. This consensus document proposes that the term 'valvular AF' is outdated and given that any definition ultimately relates to the evaluated practical use of oral anticoagulation (OAC) type, we propose a functional Evaluated Heartvalves, Rheumatic or Artificial (EHRA) categorization in relation to the type of OAC use in patients with AF, as follows: (i) EHRA Type 1 VHD, which refers to AF patients with 'VHD needing therapy with a Vitamin K antagonist (VKA); and (ii) EHRA Type 2 VHD, which refers to AF patients with 'VHD needing therapy with a VKA or a Non-VKA oral anticoagulant (NOAC)', also taking into consideration CHA2DS2VASc score risk factor components. This consensus document also summarizes current developments in the field, and provides general recommendations for the management of these patients based on the principles of evidence-based medicine.

8 Guideline Heart Team: Joint Position of the Swiss Society of Cardiology and the Swiss Society of Cardiac Surgery. 2017

Pedrazzini, Giovanni B / Ferrari, Enrico / Zellweger, Michael / Genoni, Michele. ·Swiss Society of Cardiology (SSC), Ticino, Switzerland. · Swiss Society of Cardiac Surgery (SGHC), Zurich, Switzerland. ·Thorac Cardiovasc Surg · Pubmed #28922674.

ABSTRACT: The Swiss Society of Cardiology (SSC) and the Swiss Society of Cardiac and ThoracicVascular Surgery (SSCTVS) have formulated their mutual intent of a close, patient-oriented, and expertise-based collaboration in the Heart Team Paper. The interdisciplinary dialogue between the SSC and SSCTVS reflects an attitude in decision making, which guarantees the best possible therapy for the individual patient. At the same time, it is a cornerstone of optimized process quality, placing individual interests into the background. Evaluation of the correct indication for a treatment is indeed very challenging and almost impossible to verify retrospectively. Quality in this very important health policy process can therefore only be assured by the use of mutually recognized indications, agreed upon by all involved physicians and medical specialties, whereby the capacity of those involved in the process is not important but rather their competence. These two medical societies recognize their responsibility and have incorporated international guidelines as well as specified regulations for Switzerland. Former competitors now form an integrative consulting team able to deliver a comprehensive evaluation for patients. Naturally, implementation rests with the individual caregiver. The Heart Team Paperof the SGK and SGHC, has defined guide boards within which the involved specialists maintain sufficient room to maneuver, and patients have certainty of receiving the best possible therapy they require.

9 Guideline Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. 2017

Chambers, John B / Prendergast, Bernard / Iung, Bernard / Rosenhek, Raphael / Zamorano, Jose Luis / Piérard, Luc A / Modine, Thomas / Falk, Volkmar / Kappetein, Arie Pieter / Pibarot, Phillipe / Sundt, Thoralf / Baumgartner, Helmut / Bax, Jeroen J / Lancellotti, Patrizio. ·Cardiothoracic Centre, Guy's and St Thomas' Hospitals, London, UK. · Cardiology Department, Bichat Hospital, APHP, DHU Fire and Paris-Diderot University, Paris, France. · Vienna General Hospital, University of Vienna, Vienna, Austria. · Cibercv, University Hospital Ramón y Cajal, Madrid, Spain. · Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, Liège, Belgium. · University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium. · Lille University Hospital, Lille, France. · Deutsches Herzzentrum Berlin, Berlin, Germany. · Erasmus University, Rotterdam, The Netherlands. · Department of Medicine, Laval University, Quebec, Canada. · Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, MA, USA. · Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany. · Leiden University Medical Center, Leiden, The Netherlands. · Anthea Hospital, Gruppo Villa Maria Care and Research, Bari, Italy. ·Eur J Cardiothorac Surg · Pubmed #28874032.

ABSTRACT: -- No abstract --

10 Guideline ACR Appropriateness Criteria 2017

Anonymous3660905 / Vogel-Claussen, Jens / Elshafee, Amany S M / Kirsch, Jacobo / Brown, Richard K J / Hurwitz, Lynne M / Javidan-Nejad, Cylen / Julsrud, Paul R / Kramer, Christopher M / Krishnamurthy, Rajesh / Laroia, Archana T / Leipsic, Jonathon A / Panchal, Kalpesh K / Shah, Amar B / White, Richard D / Woodard, Pamela K / Abbara, Suhny. ·Principal Author, Johns Hopkins Hospital, Baltimore, Maryland, and Medizinische Hochschule Hannover, Hannover, Germany. Electronic address: jclauss1@jhmi.edu. · Research Author, Medizinische Hochschule Hannover, Hannover, Germany, and Mansoura University Hospitals, Mansoura, Egypt. · Cleveland Clinic Florida, Weston, Florida. · University Hospital, Ann Arbor, Michigan. · Duke University Medical Center, Durham, North Carolina. · Mallinckrodt Institute of Radiology; Washington University School of Medicine, Saint Louis, Missouri. · Mayo Clinic, Rochester, Minnesota. · University of Virginia Health System, Charlottesville, Virginia; American College of Cardiology. · Nationwide Children's Hospital, Columbus, Ohio. · University of Iowa Hospitals and Clinics, Iowa City, Iowa. · St. Paul's Hospital, Vancouver, British Columbia, Canada. · University of Cincinnati Hospital, Cincinnati, Ohio. · Westchester Medical Center, Valhalla, New York. · The Ohio State University Wexner Medical Center, Columbus, Ohio. · Specialty Chair, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri. · Panel Chair, UT Southwestern Medical Center, Dallas, Texas. ·J Am Coll Radiol · Pubmed #28473068.

ABSTRACT: This article discusses imaging guidelines for five dyspnea variants: (1) dyspnea due to heart failure, ischemia not excluded; (2) dyspnea due to suspected nonischemic heart failure, ischemia excluded; (3) dyspnea due to suspected valvular heart disease, ischemia excluded; (4) dyspnea due to suspected cardiac arrhythmia, ischemia excluded; and (5) dyspnea due to suspected pericardial disease, ischemia excluded. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

11 Guideline 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2017

Nishimura, Rick A / Otto, Catherine M / Bonow, Robert O / Carabello, Blase A / Erwin, John P / Fleisher, Lee A / Jneid, Hani / Mack, Michael J / McLeod, Christopher J / O'Gara, Patrick T / Rigolin, Vera H / Sundt, Thoralf M / Thompson, Annemarie. · ·J Am Coll Cardiol · Pubmed #28315732.

ABSTRACT: -- No abstract --

12 Guideline Clinical recommendations of cardiac magnetic resonance, Part I: ischemic and valvular heart disease: a position paper of the working group 'Applicazioni della Risonanza Magnetica' of the Italian Society of Cardiology. 2017

Aquaro, Giovanni Donato / Di Bella, Gianluca / Castelletti, Silvia / Maestrini, Viviana / Festa, Pierluigi / Ait-Ali, Lamia / Masci, Pier Giorgio / Monti, Lorenzo / di Giovine, Gabriella / De Lazzari, Manuel / Cipriani, Alberto / Guaricci, Andrea I / Dellegrottaglie, Santo / Pepe, Alessia / Marra, Martina Perazzolo / Pontone, Gianluca. ·aU.O.C. Risonanza Magnetica per Immagini, Fondazione G. Monasterio CNR-Regione Toscana Pisa bUO Cardiologia, Università di Messina, Messina cIstituto Auxologico Italiano, Milano dDepartment of Cardiovascular, Respiratory, Geriatric, Anesthesiologic and Nephrologic Sciences, Sapienza University of Rome, Rome, Italy eCentre for Cardiac MR, Cardiology Unit, University Hospital Lausanne, Lausanne, Switzerland fU.O. Radiologia Diagnostica, Humanitas Hospital, Milan gDivision of Cardiology, Azienda Ospedaliera-Universitaria 'Maggiore della Carità', Eastern Piemont University, Novara hU.O. Clinica Cardiologica, Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari, Università di Padova, Padua iUnità Operativa di Cardiologia Universitaria Dipartimento di Emergenze e Trapianti di Organi (D.E.T.O.) Azienda Ospedaliera Policlinico Consorziale di Bari, Bari jLaboratorio di RM Cardiovascolare Divisione di Cardiologia Clinica Villa dei Fiori, Acerra kU.O. Cardiologia, Centro Cardiologico Monzino, Milano, Italy. ·J Cardiovasc Med (Hagerstown) · Pubmed #28072628.

ABSTRACT: Cardiac magnetic resonance (CMR) has emerged as a reliable and accurate diagnostic tool for the evaluation of patients with cardiac disease in several clinical settings and with proven additional diagnostic and prognostic value compared with other imaging modalities. This document has been developed by the working group on the 'application of CMR' of the Italian Society of Cardiology to provide a perspective on the current state of technical advances and clinical applications of CMR and to inform cardiologists on how to implement their clinical and diagnostic pathways with the inclusion of this technique in clinical practice. The writing committee consisted of members of the working group of the Italian Society of Cardiology and two external peer reviewers with acknowledged experience in the field of CMR.

13 Guideline 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. 2017

Otto, Catherine M / Kumbhani, Dharam J / Alexander, Karen P / Calhoon, John H / Desai, Milind Y / Kaul, Sanjay / Lee, James C / Ruiz, Carlos E / Vassileva, Christina M. · ·J Am Coll Cardiol · Pubmed #28063810.

ABSTRACT: -- No abstract --

14 Guideline SASCI/SCTSSA joint consensus statement and guidelines on transcatheter aortic valve implantation (TAVI) in South Africa. 2016

Scherman, Jacques / Weich, Hellmuth. ·Chris Barnard Division of Cardiothoracic Surgery, University of Cape Town, South Africa. Email: jacques.scherman@uct.ac.za. · Division of Cardiology, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa. Email: hweich@sun.ac.za. ·Cardiovasc J Afr · Pubmed #27966003.

ABSTRACT: -- No abstract --

15 Guideline The Rationale for Performance of Coronary Angiography and Stenting Before Transcatheter Aortic Valve Replacement: From the Interventional Section Leadership Council of the American College of Cardiology. 2016

Ramee, Stephen / Anwaruddin, Saif / Kumar, Gautam / Piana, Robert N / Babaliaros, Vasilis / Rab, Tanveer / Klein, Lloyd W / Anonymous11460889 / Anonymous11470889. ·Ochsner Medical Center, New Orleans, Louisiana. · Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. · Emory University/Atlanta VA Medical Center, Atlanta, Georgia. · Vanderbilt University Medical Center, Nashville, Tennessee. · Emory University School of Medicine, Atlanta, Georgia. · Rush Medical College, Chicago, Illinois. Electronic address: lloydklein@comcast.net. ·JACC Cardiovasc Interv · Pubmed #27931592.

ABSTRACT: Transcatheter aortic valve replacement (TAVR) is an effective, nonsurgical treatment option for patients with severe aortic stenosis. The optimal treatment strategy for treating concomitant coronary artery disease (CAD) has not been tested prospectively in a randomized clinical trial. Nevertheless, it is standard practice in the United States to perform coronary angiography and percutaneous coronary intervention for significant CAD at least 1 month before TAVR. All existing clinical trials were designed using this strategy. Therefore, it is wrong to extrapolate current American College of Cardiology/American Heart Association Appropriate Use Criteria against invasive procedures in asymptomatic patients to the TAVR population when evaluating the quality of care by cardiologists or hospitals. In this statement from the Interventional Section Leadership Council of the ACC, it is recommended that percutaneous coronary intervention should be considered in all patients with significant proximal coronary stenosis in major coronary arteries before TAVR, even though the indication is not covered in current guidelines.

16 Guideline [ANMCO/SIC/SICI-GISE/SICCH Consensus document: Risk stratification in elderly patients undergoing cardiac surgery and transcatheter aortic valve implantation]. 2016

Pulignano, Giovanni / Gulizia, Michele Massimo / Baldasseroni, Samuele / Bedogni, Francesco / Cioffi, Giovanni / Indolfi, Ciro / Romeo, Francesco / Murrone, Adriano / Musumeci, Francesco / Parolari, Alessandro / Patanè, Leonardo / Pino, Paolo Giuseppe / Mongiardo, Annalisa / Spaccarotella, Carmen / Di Bartolomeo, Roberto / Musumeci, Giuseppe. ·U.O.C. Cardiologia 1, Ospedale San Camillo-Forlanini, Roma. · U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione "Garibaldi", Catania. · Cardiologia Generale, AOU Careggi, Firenze. · U.O. Cardiologia-UTIC, IRCCS Policlinico San Donato, San Donato Milanese (MI). · U.O. Cardiologia e Medicina, Casa di Cura Villa Bianca, Trento. · U.O. Cardiologia - Campus Universitario, Azienda Ospedaliera Universitaria Mater Domini, Catanzaro. · U.O.C. Cardiologia e Cardiologia Interventistica, Policlinico "Tor Vergata", Roma. · Cardiologia e Fisiopatologia Cardiovascolare, Azienda Ospedaliera di Perugia, Perugia. · U.O.C. Cardiochirurgia, Ospedale San Camillo-Forlanini, Roma. · U.O. Cardiochirurgia, Centro Cardiologico Monzino IRCCS, Università degli Studi, Milano. · Presidio Cardiologico Cardiochirurgico (Centro Cuore), Centro Clinico Diagnostico G.B. Morgagni, Pedara (CT). · U.O. Cardiologia 2, Ospedale San Camillo-Forlanini, Roma. · U.O. Cardiochirurgia, Ospedale Policlinico S. Orsola-Malpighi, Bologna. · Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo. ·G Ital Cardiol (Rome) · Pubmed #27869890.

ABSTRACT: Aortic stenosis is one the most frequent valvular diseases in developed countries, and its impact on public healthcare resources and assistance is increasing. A substantial proportion of elderly patients with severe aortic stenosis is frequently not eligible for surgery because of advanced age, frailty and multiple comorbidities. Transcatheter aortic valve implantation (TAVI) enables the treatment of very elderly patients at high or prohibitive surgical risk considered ineligible for surgery and with an acceptable life expectancy. However, a significant proportion of patients die or do not achieve an improvement of quality of life in the short to medium-term follow-up. It is important to determine: 1) whether and how much patient frailty influences the procedural risk; 2) whether quality of life and the individual patient survival are influenced by aortic valve disease alone or by other associated factors; 3) whether a geriatric specialist intervention to evaluate and correct other diseases with their potential or already evident disabilities can improve the results of TAVI, in particular patient quality of life. Consequently, in addition to risk stratification with conventional tools, a number of factors including multimorbidity, disability, frailty and cognitive function should be considered in order to assess the expected benefit of TAVI. Preoperative optimization through a multidisciplinary approach with a Heart Team can counteract the multiple damage (cardiac, neurological, muscular, respiratory, renal) that can potentially worsen the reduced physiological reserves characteristic of frailty. The systematic implementation into clinical practice of multidimensional assessment instruments of frailty and cognitive function for screening and exercise, and the adoption of specific care pathways should facilitate this task.

17 Guideline 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. 2016

Ponikowski, Piotr / Voors, Adriaan A / Anker, Stefan D / Bueno, Héctor / Cleland, John G F / Coats, Andrew J S / Falk, Volkmar / González-Juanatey, José Ramón / Harjola, Veli-Pekka / Jankowska, Ewa A / Jessup, Mariell / Linde, Cecilia / Nihoyannopoulos, Petros / Parissis, John T / Pieske, Burkert / Riley, Jillian P / Rosano, Giuseppe M C / Ruilope, Luis M / Ruschitzka, Frank / Rutten, Frans H / van der Meer, Peter / Anonymous6630868. · ·Eur Heart J · Pubmed #27206819.

ABSTRACT: -- No abstract --

18 Guideline Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill Patients-Part II: Cardiac Ultrasonography. 2016

Levitov, Alexander / Frankel, Heidi L / Blaivas, Michael / Kirkpatrick, Andrew W / Su, Erik / Evans, David / Summerfield, Douglas T / Slonim, Anthony / Breitkreutz, Raoul / Price, Susanna / McLaughlin, Matthew / Marik, Paul E / Elbarbary, Mahmoud. ·1Division of Pulmonary and Critical Care Medicine Eastern Virginia Medical School, Norfolk, VA. 2Los Angeles, CA. 3Department of Emergency Medicine, St Francis Hospital, University of South Carolina School of Medicine, Columbus, GA. 4Foothills Medical Centre and the University of Calgary, Calgary, AB, Canada. 5Department of Anesthesiology and Critical Care Medicine The Johns Hopkins University School of Medicine, Baltimore, MD. 6Emergency Ultrasound, Department of Emergency Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA. 7Aerospace and Critical Care Medicine, Mayo Clinic, Rochester, MN. 8Renown Health Reno, Nevada. 9Department of Anesthesiology, University Hospital of the Sarrland, Homburg-Saar, Germany. 10Clinics of Anesthesiology, Intensive Care and Pain Therapy, Hospital of the Goethe University, Frankfurt, Germany. 11Royal Brompton Hospital, London, United Kingdom. 12Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA. 13King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia. 14Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. ·Crit Care Med · Pubmed #27182849.

ABSTRACT: OBJECTIVE: To establish evidence-based guidelines for the use of bedside cardiac ultrasound, echocardiography, in the ICU and equivalent care sites. METHODS: Grading of Recommendations, Assessment, Development and Evaluation system was used to rank the "levels" of quality of evidence into high (A), moderate (B), or low (C) and to determine the "strength" of recommendations as either strong (strength class 1) or conditional/weak (strength class 2), thus generating six "grades" of recommendations (1A-1B-1C-2A-2B-2C). Grading of Recommendations, Assessment, Development and Evaluation was used for all questions with clinically relevant outcomes. RAND Appropriateness Method, incorporating the modified Delphi technique, was used in formulating recommendations related to terminology or definitions or in those based purely on expert consensus. The process was conducted by teleconference and electronic-based discussion, following clear rules for establishing consensus and agreement/disagreement. Individual panel members provided full disclosure and were judged to be free of any commercial bias. RESULTS: Forty-five statements were considered. Among these statements, six did not achieve agreement based on RAND appropriateness method rules (majority of at least 70%). Fifteen statements were approved as conditional recommendations (strength class 2). The rest (24 statements) were approved as strong recommendations (strength class 1). Each recommendation was also linked to its level of quality of evidence and the required level of echo expertise of the intensivist. Key recommendations, listed by category, included the use of cardiac ultrasonography to assess preload responsiveness in mechanically ventilated (1B) patients, left ventricular (LV) systolic (1C) and diastolic (2C) function, acute cor pulmonale (ACP) (1C), pulmonary hypertension (1B), symptomatic pulmonary embolism (PE) (1C), right ventricular (RV) infarct (1C), the efficacy of fluid resuscitation (1C) and inotropic therapy (2C), presence of RV dysfunction (2C) in septic shock, the reason for cardiac arrest to assist in cardiopulmonary resuscitation (1B-2C depending on rhythm), status in acute coronary syndromes (ACS) (1C), the presence of pericardial effusion (1C), cardiac tamponade (1B), valvular dysfunction (1C), endocarditis in native (2C) or mechanical valves (1B), great vessel disease and injury (2C), penetrating chest trauma (1C) and for use of contrast (1B-2C depending on indication). Finally, several recommendations were made regarding the use of bedside cardiac ultrasound in pediatric patients ranging from 1B for preload responsiveness to no recommendation for RV dysfunction. CONCLUSIONS: There was strong agreement among a large cohort of international experts regarding several class 1 recommendations for the use of bedside cardiac ultrasound, echocardiography, in the ICU. Evidence-based recommendations regarding the appropriate use of this technology are a step toward improving patient outcomes in relevant patients and guiding appropriate integration of ultrasound into critical care practice.

19 Guideline [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. 2016

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Plonska-Gosciniak, Edyta / Price, Susanna / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Tornos Mas, Pilar / Vilacosta, Isidre / Zamorano, Jose Luis / Anonymous3440865. · ·G Ital Cardiol (Rome) · Pubmed #27093212.

ABSTRACT: -- No abstract --

20 Guideline Echocardiographic diagnosis of adult valvular heart disease. 2016

Anonymous13090863. · ·J Med Ultrason (2001) · Pubmed #27038348.

ABSTRACT: -- No abstract --

21 Guideline Surgery for aortic dilatation in patients with bicuspid aortic valves: A statement of clarification from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2016

Anonymous1350862 / Hiratzka, Loren F / Creager, Mark A / Isselbacher, Eric M / Svensson, Lars G / Anonymous1360862 / Nishimura, Rick A / Bonow, Robert O / Guyton, Robert A / Sundt, Thoralf M. · ·J Thorac Cardiovasc Surg · Pubmed #26995623.

ABSTRACT: Two guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and collaborating societies address the risk of aortic dissection in patients with bicuspid aortic valves and severe aortic enlargement: The "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease" (J Am Coll Cardiol. 2010;55:e27-130) and the "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease" (J Am Coll Cardiol. 2014;63:e57-185). However, the 2 guidelines differ with regard to the recommended threshold of aortic root or ascending aortic dilatation that would justify surgical intervention in patients with bicuspid aortic valves. The ACC and AHA therefore convened a subcommittee representing members of the 2 guideline writing committees to review the evidence, reach consensus, and draft a statement of clarification for both guidelines. This statement of clarification uses the ACC/AHA revised structure for delineating the Class of Recommendation and Level of Evidence to provide recommendations that replace those contained in Section 9.2.2.1 of the thoracic aortic disease guideline and Section 5.1.3 of the valvular heart disease guideline.

22 Guideline 2015 The American Association for Thoracic Surgery Consensus Guidelines: Ischemic mitral valve regurgitation. 2016

Anonymous1340862 / Kron, Irving L / Acker, Michael A / Adams, David H / Ailawadi, Gorav / Bolling, Steven F / Hung, Judy W / Lim, D Scott / LaPar, Damien J / Mack, Michael J / O'Gara, Patrick T / Parides, Michael K / Puskas, John D. ·University of Virginia, Charlottesville, Va. Electronic address: ilk@virginia.edu. · University of Pennsylvania, Philadelphia, Pa. · Mount Sinai Medical Center, New York, NY. · University of Virginia, Charlottesville, Va. · University of Michigan, Ann Arbor, Mich. · Massachusetts General Hospital, Boston, Mass. · Baylor Health System, Plano, Tex. · Brigham and Women's Hospital, Boston, Mass. ·J Thorac Cardiovasc Surg · Pubmed #26995621.

ABSTRACT: -- No abstract --

23 Guideline Guidelines for Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (JCS 2012) - Digest Version . 2016

Anonymous1850857. · ·Circ J · Pubmed #26841693.

ABSTRACT: -- No abstract --

24 Guideline Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2016

Hiratzka, Loren F / Creager, Mark A / Isselbacher, Eric M / Svensson, Lars G / Nishimura, Rick A / Bonow, Robert O / Guyton, Robert A / Sundt, Thoralf M. · ·J Am Coll Cardiol · Pubmed #26658475.

ABSTRACT: Two guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and collaborating societies address the risk of aortic dissection in patients with bicuspid aortic valves and severe aortic enlargement: the "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease" (J Am Coll Cardiol 2010;55:e27-130) and the "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease" (J Am Coll Cardiol 2014;63:e57-185). However, the 2 guidelines differ with regard to the recommended threshold of aortic root or ascending aortic dilatation that would justify surgical intervention in patients with bicuspid aortic valves. The ACC and AHA therefore convened a subcommittee representing members of the 2 guideline writing committees to review the evidence, reach consensus, and draft a statement of clarification for both guidelines. This statement of clarification uses the ACC/AHA revised structure for delineating the Class of Recommendation and Level of Evidence to provide recommendations that replace those contained in Section 9.2.2.1 of the thoracic aortic disease guideline and Section 5.1.3 of the valvular heart disease guideline.

25 Guideline 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). 2015

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Plonska-Gosciniak, Edyta / Price, Susanna / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Tornos Mas, Pilar / Vilacosta, Isidre / Zamorano, Jose Luis / Anonymous350841. · ·Eur Heart J · Pubmed #26320109.

ABSTRACT: -- No abstract --

Next